EA202190219A1 - Лечение и предупреждение повреждения из-за воздействия радиационного излучения - Google Patents

Лечение и предупреждение повреждения из-за воздействия радиационного излучения

Info

Publication number
EA202190219A1
EA202190219A1 EA202190219A EA202190219A EA202190219A1 EA 202190219 A1 EA202190219 A1 EA 202190219A1 EA 202190219 A EA202190219 A EA 202190219A EA 202190219 A EA202190219 A EA 202190219A EA 202190219 A1 EA202190219 A1 EA 202190219A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
radiation
damage due
introducing
Prior art date
Application number
EA202190219A
Other languages
English (en)
Inventor
Элза Компт
Патрик Морель
Софи Грив-Жерфаньон
Сириль Лаво
Лоррейн Бениньо-Антон
Жан-Клод Морель
Original Assignee
Медзис Фарма
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Медзис Фарма filed Critical Медзис Фарма
Publication of EA202190219A1 publication Critical patent/EA202190219A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

Изобретение относится к лечению и/или предупреждению радиационного повреждения путем введения обратно-мицеллярной системы.
EA202190219A 2018-07-06 2019-07-05 Лечение и предупреждение повреждения из-за воздействия радиационного излучения EA202190219A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862694637P 2018-07-06 2018-07-06
PCT/EP2019/068099 WO2020008032A1 (en) 2018-07-06 2019-07-05 Treatment and prevention of injury due to radiation exposure

Publications (1)

Publication Number Publication Date
EA202190219A1 true EA202190219A1 (ru) 2021-07-22

Family

ID=67314731

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190219A EA202190219A1 (ru) 2018-07-06 2019-07-05 Лечение и предупреждение повреждения из-за воздействия радиационного излучения

Country Status (11)

Country Link
US (2) US11793831B2 (ru)
EP (1) EP3817725A1 (ru)
JP (1) JP7399162B2 (ru)
CN (1) CN112672735A (ru)
AU (1) AU2019298653A1 (ru)
BR (1) BR112021000121A2 (ru)
CA (1) CA3103704A1 (ru)
EA (1) EA202190219A1 (ru)
IL (1) IL279610A (ru)
WO (1) WO2020008032A1 (ru)
ZA (1) ZA202100752B (ru)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652512A1 (en) * 2004-11-02 2006-05-03 Medesis Pharma Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
US8877237B2 (en) * 2010-03-24 2014-11-04 Medesis Pharma Reverse micelle system comprising nucleic acids and use thereof
WO2011117333A2 (en) * 2010-03-24 2011-09-29 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
US20140023701A1 (en) 2011-04-07 2014-01-23 Nugevity Llc Method and Composition for Ameliorating the Effects tor a Subject Exposed to Radiation or Other Sources of Oxidative Stress
EA037605B1 (ru) 2014-02-18 2021-04-20 Медзис Фарма Применение обратно-мицеллярных систем для доставки реагентов, хелатирующих радионуклиды и металлы
EP3319588A1 (en) 2015-07-09 2018-05-16 Medesis Pharma In situ preparation of cyano-bridged metal nanop articles within a biocompatible reverse micellar system

Also Published As

Publication number Publication date
US11793831B2 (en) 2023-10-24
IL279610A (en) 2021-03-01
WO2020008032A1 (en) 2020-01-09
JP2021529831A (ja) 2021-11-04
US20240000832A1 (en) 2024-01-04
CA3103704A1 (en) 2020-01-09
ZA202100752B (en) 2023-06-28
CN112672735A (zh) 2021-04-16
BR112021000121A2 (pt) 2021-04-06
EP3817725A1 (en) 2021-05-12
AU2019298653A1 (en) 2021-01-14
JP7399162B2 (ja) 2023-12-15
US20210315931A1 (en) 2021-10-14

Similar Documents

Publication Publication Date Title
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122148T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
CY1120950T1 (el) Θεραπεια ινωσης
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
DK3600281T3 (da) Kombinationsbehandling til behandling eller forebyggelse af tumorer
EA201990615A1 (ru) Пирролобензодиазепиновые конъюгаты
MD3209309T2 (ro) Compoziții care conțin tulpini bacteriene
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
TR201901445T4 (tr) Il2rbeta/yaygın gamma zinciri antikorları.
EA201790998A1 (ru) Иммуннорегуляторные агенты
CY1124406T1 (el) Αζασετρονη για χρηση στη θεραπεια της απωλειας ακοης
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
EA201591278A1 (ru) Композиции, содержащие c1-inh, и способы профилактики и лечения расстройств, ассоциированых с дефицитом ингибитора с1 эстеразы
TR201905233T4 (tr) Dirençli bakteriyel enfeksiyonların tedavisine yönelik kombinasyon tedavisi.
EA201890810A1 (ru) Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение
EA201891644A1 (ru) Антибактериальные соединения и их применение
EA202190475A1 (ru) Мини-gde для лечения гликогеноза iii типа
CY1124286T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
EA202090424A1 (ru) Бициклические ингибиторы гистондеацетилазы
CY1126054T1 (el) Πεπτιδια για θεραπεια και αποτροπη διαβητη και συναφων διαταραχων
EA201992302A1 (ru) Соединения, используемые в качестве ингибиторов alcat1
EA201990064A1 (ru) Противомалярийные композиции и варианты их применения